Toll-like receptor 9 processing: The key event in Toll-like receptor 9 activation?

Immunology Letters

Volumn 149, Issue 1-2, 2013, Pages 85-87

  Bauer, Stefan ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Asparagine endopeptidase (AEP); Cathepsin; TLR9 processing

Indexed keywords

ASPARAGINE ENDOPEPTIDASE; BACTERIAL DNA; CATHEPSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROTEINASE; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA;

ADAPTIVE IMMUNITY; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CONFORMATIONAL TRANSITION; CPG ISLAND; CYTOKINE PRODUCTION; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; CATHEPSINS; DNA, BACTERIAL; DNA, VIRAL; ENDOSOMES; HUMANS; IMMUNITY, INNATE; LYSOSOMES; PROTEOLYSIS; TOLL-LIKE RECEPTOR 9;

EID: 84872717154     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.11.003     Document Type: Review

References (38)

1. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
2. Tabeta K., Hoebe K., Janssen E.M., Du X., Georgel P., Crozat K., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006, 7:156-164.
3. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190-198.
4. Kim Y.M., Brinkmann M.M., Paquet M.E., Ploegh H.L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008, 452:234-238.
5. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
6. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002, 3:499.
7. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002, 3:196-200.
8. Lee J., Chuang T.H., Redecke V., She L., Pitha P.M., Carson D.A., et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003, 100:6646-6651.
9. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
10. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
11. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005, 11:263-270.
12. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
13. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001, 98:9237-9242.
14. Takeshita F., Leifer C.A., Gursel I., Ishii K.J., Takeshita S., Gursel M., et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001, 167:3555-3558.
15. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
16. Yasuda K., Yu P., Kirschning C.J., Schlatter B., Schmitz F., Heit A., et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol 2005, 174:6129-6136.
17. Yasuda K., Rutz M., Schlatter B., Metzger J., Luppa P.B., Schmitz F., et al. CpG motif-independent activation of TLR9 upon endosomal translocation of natural phosphodiester DNA. Eur J Immunol 2006, 36:431-436.
18. Haas T., Metzger J., Schmitz F., Heit A., Muller T., Latz E., et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 2008, 28:315-323.
19. Barton G.M., Kagan J.C., Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006, 7:49-56.
20. Coch C., Busch N., Wimmenauer V., Hartmann E., Janke M., Abdel-Mottaleb M.M., et al. Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNA. J Leukoc Biol 2009, 86:663-670.
21. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 2004, 34:2541-2550.
22. Kindrachuk J., Potter J.E., Brownlie R., Ficzycz A.D., Griebel P.J., Mookherjee N., et al. Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9. J Biol Chem 2007, 282:13944-13953.
23. Asagiri M., Hirai T., Kunigami T., Kamano S., Gober H.J., Okamoto K., et al. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 2008, 319:624-627.
24. Matsumoto F., Saitoh S., Fukui R., Kobayashi T., Tanimura N., Konno K., et al. Cathepsins are required for Toll-like receptor 9 responses. Biochem Biophys Res Commun 2008, 367:693-699.
25. Ewald S.E., Lee B.L., Lau L., Wickliffe K.E., Shi G.P., Chapman H.A., et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008, 456:658-662.
26. Park B., Brinkmann M.M., Spooner E., Lee C.C., Kim Y.M., Ploegh H.L. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 2008, 9:1407-1414.
27. Sepulveda F.E., Maschalidi S., Colisson R., Heslop L., Ghirelli C., Sakka E., et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 2009, 31:737-748.
28. Ewald S.E., Engel A., Lee J., Wang M., Bogyo M., Barton G.M. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 2011, 208:643-651.
29. Garcia-Cattaneo A., Gobert F.X., Muller M., Toscano F., Flores M., Lescure A., et al. Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci USA 2012, 109:9053-9058.
30. Ha S.D., Martins A., Khazaie K., Han J., Chan B.M., Kim S.O. Cathpsin B is involved in the trafficking of TNF-alpha-containing vesicles to the plasma membrane in macrophages. J Immunol 2008, 181:690-697.
31. Leung P., Pickarski M., Zhuo Y., Masarachia P.J., Duong L.T. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone 2011, 49:623-635.
32. Cornelie S., Hoebeke J., Schacht A.M., Bertin B., Vicogne J., Capron M., et al. Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J Biol Chem 2004, 279:15124-15129.
33. Avalos A.M., Ploegh H.L. Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9. Eur J Immunol 2011, 41:2820-2827.
34. Chen J., Nag S., Vidi P.A., Irudayaraj J. Single molecule in vivo analysis of toll-like receptor 9 and CpG DNA interaction. PLoS ONE 2011, 6:e17991.
35. Li Y., Berke I.C., Modis Y. DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J 2011, 31:919-931.
36. Peter M.E., Kubarenko A.V., Weber A.N., Dalpke A.H. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J Immunol 2009, 182:7690-7697.
37. Iavarone C., Ramsauer K., Kubarenko A.V., Debasitis J.C., Leykin I., Weber A.N., et al. A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding. J Immunol 2011, 186:4213-4222.
38. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor. Nat Immunol 2007, 8:772-779.